IGM Financial recorded $343.3 billion in assets under management and advisement as of June 30, a record high and up 20.9% ...

During November 2025, an institutional client made portfolio construction changes within their offering that resulted in an allocation of $600 million into Mackenzie ETFs. Glossary of Terms Assets ...

MOUNTAIN VIEW, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing IgM antibodies, today ...

On Tuesday, IGM Biosciences Inc. (NASDAQ:IGMS) announced a strategic pivot and pipeline transformation to accelerate and deepen its leadership in developing T cell-engaging IgM antibodies for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies ...

MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...

IGM Financial Inc. (IGM) (TSX: IGM) today reported record high total assets under management and advisement of $343.3 billion at June 30, 2026, up 20.9% from $283.9 billion at June 30, 2025. Total ...